LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Fluorescent Detection System Developed for Identifying Cancer

By LabMedica International staff writers
Posted on 14 May 2014
Image: The Fluoview 1000 confocal fluorescence microscope (Photo courtesy of Olympus).
Image: The Fluoview 1000 confocal fluorescence microscope (Photo courtesy of Olympus).
A new water-soluble fluorescent detection system that is extremely sensitive to pyrophosphate (PPi) has been discovered that might lead to the development of a method for early detection of cancer cells.

The highly sensitive probes or sensors that are able to report the PPi level could lead to improved cancer diagnostics, since PPi plays a key role in energy transduction, DNA replication and other metabolic processes that seriously diverge in cancer cells.

Scientists at the University of Jyväskylä (Finland) developed a simple metal complex which shows an intense orange fluorescent color in the presence of very low concentration of pyrophosphate (PPi) in water. The complex, also called a probe, had almost 1,000 times higher level of response than earlier methods and an unprecedented sensitivity to detect PPi at a subnanomolar level with a limit of detection (LOD) of 0.8 nM. The discovery represents the first water-soluble fluorescent sensor that is capable of detecting pyrophosphate at this sensitivity level under physiological conditions.

The investigators were able to show that the probe can image the pyrophosphate in the nuclei of living (HeLa) cells, making it an excellent probe for live cell pyrophosphate imaging. The HeLa cells, originally from Henrietta Lack's cervix carcinoma, are the most long-lived human cancer cell line and are often used as a cancer cell model. In addition to their applicability in water, they can easily be formulated into a hydrogel and coated onto paper strips for low-cost pyrophosphate detection. Fluorescence spectra were obtained on a Varian Cary Eclipse Fluorescence spectrophotometer (Agilent Technologies; Santa Clara, CA, USA) and confocal fluorescence microscopy images were recorded in the Olympus Fluoview 1000 setup (Olympus; Tokyo, Japan).

The authors concluded that a simple terpyridine-Zn(II) complex was efficient and selective in sensing of PPi in water. The ZnCl2L receptor complex showed remarkable fluorescent response, around 500-fold, and an excellent sensitivity toward PPi that allows a subnanomolar level detection. The ZnCl2L was found to form a hydrogel which was subsequently used to make gel coated paper strips for easy, low-cost detection of PPi. They believe these novel findings would be beneficial for the development of commercially viable chemosensory alternatives to enzyme and protein based assays in diagnostics and other clinical applications.

Related Links:

University of Jyväskylä
Agilent Technologies
Olympus 


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
ESR Analyzer
TEST1 2.0

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more